@FiercePharma: Pfizer tops drug-sampling list with $2.7B in spending. Report | Follow @FiercePharma
> An international group that helps ensure patient access to HIV drugs is warning that Bristol-Myers Squibb's (NYSE: BMY) plans to close a French factory could leave thousands of babies without a life-saving treatment. Report
> Genzyme says it has nominated Dennis Fenton, a former executive vice president at biotechnology company Amgen, to its board of directors. Release | Report
> Astellas Pharma says it has successfully completed its $4 billion tender offer for OSI Pharmaceuticals, receiving offers for 93 percent of the U.S. cancer drug-developer's outstanding shares. Report
> Buoyed by its recent $3.72 billion acquisition of Piramal Healthcare's solutions business, Abbott Laboratories is expecting sales in India to exceed $2.5 billion by 2020. Report
> Bosnia's Muslim-Croat federation will not rush with a new auction of its stake in top drugs firm Bosnalijek after a previous transaction failed, the privatization agency said. Report
> Ranbaxy Laboratories says its unit has launched atorvastatin, a generic form of Pfizer's blockbuster Lipitor cholesterol fighter, in South Africa. Report
> APP Pharmaceuticals says it has won FDA approval to market oxaliplatin, the generic version of Sanofi-Aventis' cancer drug Eloxatin. Report
> Chinese drugmaker Simcere Pharmaceutical said it is taking a larger stake in a company that makes injectable stroke-management drugs. Release | Report
Biotech News
@FierceBiotech: BMS, Pfizer cancer drugs take starring roles at ASCO. Article | Follow @FierceBiotech
@JohnCFierce: WHO chief denies private co.s influenced pandemic plan, won't name advisers. Secrecy will always inspire distrust. Report | Follow @JohnCFierce
> Forest Labs scoops up diabetes programs in $1.1 billion TransTech deal. News
> Biogen board promises to name a new CEO soon. Report
> Sanofi CEO: Still in the hunt for new drug deals. Article
> Merck KGaA resubmits oral MS drug to FDA. Story
Biotech Research News
> Cholesterol levels are 'remotely' controlled by ghrelin. Story
> Inhibiting key enzyme will reduce deaths from septic shock. Item
> Harvard spinoff promises genome sequencing for $30. News
> RNA institute to be unveiled at Albany school. Story
> George Church takes lead role commercializing genomics. Report
Manufacturing News
> Cambrex automates plant processes. Article
> GSK, academics team to print APIs onto tablets. News
> USGS: Pharma facilities release contaminants. Report
> J&J hands Congress 20K pages of Tylenol documentation. Story
> GSK rolls out 2D data-matrix system. News
And Finally... Dengue fever has re-entered the U.S. via the Florida Keys after an absence of 65 years. Report